TPP1 and tuberculosis: Based on the need for new combination treatments (MMV: TPP1) that effectively cure patients but are also able to impact on transmission, here we propose a TB in vivo protocol suitable for characterizing TB effects of compounds given in combination in the P. berghei murine model.